These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7173522)
1. Muscle protein breakdown in uncontrolled diabetes as assessed by urinary 3-methylhistidine excretion. Marchesini G; Forlani G; Zoli M; Vannini P; Pisi E Diabetologia; 1982 Nov; 23(5):456-8. PubMed ID: 7173522 [TBL] [Abstract][Full Text] [Related]
2. Muscle protein catabolism in diabetes: 3-methylhistidine excretion in the spontaneously diabetic "BB" rat. Nakhooda AF; Wei CN; Marliss EB Metabolism; 1980 Dec; 29(12):1272-7. PubMed ID: 7005619 [TBL] [Abstract][Full Text] [Related]
3. Urinary 3-methylhistidine excretion in juvenile-onset diabetics: evidence of increased protein catabolism in the absence of ketoacidosis. Huszar G; Koivisto V; Davis E; Felig P Metabolism; 1982 Feb; 31(2):188-91. PubMed ID: 7043169 [TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown. Elia M; Carter A; Bacon S; Winearls CG; Smith R Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020 [TBL] [Abstract][Full Text] [Related]
5. [3-Methylhistidine as a parameter for the determination of muscle proteolysis in the post-stress syndrome and in diabetes mellitus]. Buchholz-Wimmer GB; Wimmer W; Herbertz L; Reinauer H Infusionsther Klin Ernahr; 1984 Jun; 11(3):168-74. PubMed ID: 6434416 [TBL] [Abstract][Full Text] [Related]
6. Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation. Rennie MJ; Bennegård K; Edén E; Emery PW; Lundholm K Metabolism; 1984 Mar; 33(3):250-6. PubMed ID: 6694565 [TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of 3-methylhistidine as an index of muscle protein catabolism in postoperative trauma: the effect of parenteral nutrition. Neuhäuser M; Bergström J; Chao L; Holmström J; Nordlund L; Vinnars E; Fürst P Metabolism; 1980 Dec; 29(12):1206-13. PubMed ID: 6779092 [TBL] [Abstract][Full Text] [Related]
8. Muscle-protein catabolism after injury in man, as measured by urinary excretion of 3-methylhistidine. Williamson DH; Farrell R; Kerr A; Smith R Clin Sci Mol Med; 1977 May; 52(5):527-33. PubMed ID: 862346 [TBL] [Abstract][Full Text] [Related]
9. Age-dependent changes in the rate of myofibrillar protein degradation in humans as assessed by 3-methylhistidine and creatinine excretion. Tomas FM; Ballard FJ; Pope LM Clin Sci (Lond); 1979 Apr; 56(4):341-6. PubMed ID: 477219 [TBL] [Abstract][Full Text] [Related]
10. [Urinary excretion of 3-methylhistidine. Value and application to the study of protein catabolism]. Richard JL; Rodier M; Bringer J; Cavalie G; Claustres M; Bellet H; Mirouze J Presse Med; 1985 Jan; 14(2):91-4. PubMed ID: 3156332 [TBL] [Abstract][Full Text] [Related]
11. The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Burman KD; Wartofsky L; Dinterman RE; Kesler P; Wannemacher RW Metabolism; 1979 Aug; 28(8):805-13. PubMed ID: 454518 [TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma. Long CL; Birkhahn RH; Geiger JW; Betts JE; Schiller WR; Blakemore WS Metabolism; 1981 Aug; 30(8):765-76. PubMed ID: 6790901 [TBL] [Abstract][Full Text] [Related]
13. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism]. Beylot M; Riou JP; Sautot G; Mornex R Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442 [TBL] [Abstract][Full Text] [Related]
14. Excretion of 3-methylhistidine in nonobese fasting subjects. Garty R; Vaisman H; Tröstler N Isr J Med Sci; 1985 Oct; 21(10):817-21. PubMed ID: 3908395 [TBL] [Abstract][Full Text] [Related]
15. Muscle protein breakdown in thyrotoxicosis assessed by urinary 3-methylhistidine excretion. Yates RO; Connor H; Woods HF Ann Nutr Metab; 1981; 25(4):262-7. PubMed ID: 7305291 [TBL] [Abstract][Full Text] [Related]
16. N tau-Methylhistidine excretion and myofibrillar protein breakdown in patients receiving intravenous or enteral nutrition. Holbrook IB; Gross E; Milewski PJ; Shipley K; Irving MH Clin Sci (Lond); 1980 Sep; 59(3):211-4. PubMed ID: 6775857 [TBL] [Abstract][Full Text] [Related]
17. Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism. Neuhäuser M; Bässler KH Z Ernahrungswiss; 1984 Sep; 23(3):171-80. PubMed ID: 6506809 [TBL] [Abstract][Full Text] [Related]
18. Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N tau-methylhistidine. Tomas FM; Munro HN; Young VR Biochem J; 1979 Jan; 178(1):139-46. PubMed ID: 435272 [TBL] [Abstract][Full Text] [Related]
19. Musle protein breakdown rates in humans based on Ntau-methylhistidine (3-methylhistidine) content of mixed proteins in skeletal muscle and urinary output of Ntau-methylhistidine. Bilmazes C; Uauy R; Haverberg LN; Munro HN; Young VR Metabolism; 1978 May; 27(5):525-30. PubMed ID: 642824 [TBL] [Abstract][Full Text] [Related]
20. 3-Methylhistidine excretion and the urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown. Rennie MJ; Millward DJ Clin Sci (Lond); 1983 Sep; 65(3):217-25. PubMed ID: 6872456 [No Abstract] [Full Text] [Related] [Next] [New Search]